Evidence map›Paper›PMID 27590114›Full record

ArticleImmunity2016

Normalizing Microbiota-Induced Retinoic Acid Deficiency Stimulates Protective CD8(+) T Cell-Mediated Immunity in Colorectal Cancer.

Nupur Bhattacharya, Robert Yuan, Tyler R Prestwood, Hweixian Leong Penny, Michael A DiMaio, Nathan E Reticker-Flynn, Charles R Krois, Justin A Kenkel, Tho D Pham, Yaron Carmi and 7 more

Open access · bronzeAbstract read
In one paragraph

Article in Immunity, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 97 papers.

0numbers the graph read from it
0cells of the map it votes in
97citing papers in PubMed
8.2field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

97 citing papers in PubMed, 162 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Review
  6. ATRA upregulates OTUD6B to recruit CD8Cell death & disease · 2025
    Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Review
  19. Review
  20. Article

37 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 4 institutions in 2 countries.

Nupur BhattacharyaDepartment of Pathology, Stanford University School of Medicine (Blood Center), 3373 Hillview Avenue, Palo Alto, CA 94304, USA. Electronic address: nupur26@stanford.edu.
Robert YuanDepartment of Pathology, Stanford University School of Medicine (Blood Center), 3373 Hillview Avenue, Palo Alto, CA 94304, USA.
Tyler R PrestwoodDepartment of Pathology, Stanford University School of Medicine (Blood Center), 3373 Hillview Avenue, Palo Alto, CA 94304, USA; Institute for Stem Cell Biology and Regenerative Medicine, Stanford University School of Medicine, 265 Campus Drive, Stanford, CA 94305, USA.
Hweixian Leong PennyDepartment of Pathology, Stanford University School of Medicine (Blood Center), 3373 Hillview Avenue, Palo Alto, CA 94304, USA.
Michael A DiMaioDepartment of Pathology, Stanford University, 300 Pasteur Drive, Stanford, CA 94305, USA.
Nathan E Reticker-FlynnDepartment of Pathology, Stanford University School of Medicine (Blood Center), 3373 Hillview Avenue, Palo Alto, CA 94304, USA.
Charles R KroisGraduate Program in Metabolic Biology, Department of Nutritional Sciences and Toxicology, University of California, Berkeley, Berkeley, CA 94720, USA.
Justin A KenkelDepartment of Pathology, Stanford University School of Medicine (Blood Center), 3373 Hillview Avenue, Palo Alto, CA 94304, USA.
Tho D PhamDepartment of Pathology, Stanford University School of Medicine (Blood Center), 3373 Hillview Avenue, Palo Alto, CA 94304, USA.
Yaron CarmiDepartment of Pathology, Stanford University School of Medicine (Blood Center), 3373 Hillview Avenue, Palo Alto, CA 94304, USA.
Lorna TolentinoDepartment of Pathology, Stanford University School of Medicine (Blood Center), 3373 Hillview Avenue, Palo Alto, CA 94304, USA.
Okmi ChoiDepartment of Pathology, Stanford University School of Medicine (Blood Center), 3373 Hillview Avenue, Palo Alto, CA 94304, USA.
Reyna HulettDepartment of Pathology, Stanford University School of Medicine (Blood Center), 3373 Hillview Avenue, Palo Alto, CA 94304, USA.
Jinshan WangGraduate Program in Metabolic Biology, Department of Nutritional Sciences and Toxicology, University of California, Berkeley, Berkeley, CA 94720, USA.
Daniel A WinerDepartment of Pathology, University Health Network, and Departments of Laboratory Medicine and Pathobiology, and Immunology, University of Toronto, Toronto, ON M5G 2N2, Canada.
Joseph L NapoliGraduate Program in Metabolic Biology, Department of Nutritional Sciences and Toxicology, University of California, Berkeley, Berkeley, CA 94720, USA.
Edgar G EnglemanDepartment of Pathology, Stanford University School of Medicine (Blood Center), 3373 Hillview Avenue, Palo Alto, CA 94304, USA. Electronic address: edgareng@stanford.edu.
Stanford University · USStanford Blood Center · USUniversity of California, Berkeley · USUniversity of Toronto · CA

Funding

MOLECULAR &CELLULAR IMMUNOBIOLOGYT32AI007290 · NIAID · STANFORD UNIVERSITY · PI Sean Curtis Bendall, Olivia M Martinez · 1985 to 2026
$27.0M
Spatial-Genomic Integrative Multi-Species Analysis of Lymph Node MetastasisU54CA209971 · NCI · STANFORD UNIVERSITY · PI NOLAN, GARRY P, PLEVRITIS, SYLVIA KATINA · 2016 to 2021
$11.0M
Biology and Immunology of Pancreatic Cancer Stem Cells in a Novel Mouse ModelU01CA141468 · NCI · STANFORD UNIVERSITY · PI ENGLEMAN, EDGAR G. · 2009 to 2013
$2.4M
Radiotherapy as Immunotherapy of TumorsR01CA163441 · NCI · STANFORD UNIVERSITY · PI STROBER, SAMUEL · 2012 to 2016
$2.2M
Applicability of Mouse Breast Cancer Models to Tumor-Immune Network InvestigationR01CA196657 · NCI · STANFORD UNIVERSITY · PI ENGLEMAN, EDGAR G. · 2015 to 2017
$1.7M
Development of a glycopeptide vaccine for cancer metastasisF32CA189408 · NCI · STANFORD UNIVERSITY · PI RETICKER-FLYNN, NATHAN EDWARD · 2014 to 2016
$164k
Immunological Targeting of Colon Cancer Stem CellsF30CA196145 · NCI · STANFORD UNIVERSITY · PI PRESTWOOD, TYLER R. · 2015 to 2016
$71k
NCI NIH HHS F30 CA196145NCI NIH HHS F32 CA189408NCI NIH HHS R01 CA163441NCI NIH HHS R01 CA196657NCI NIH HHS U01 CA141468NCI NIH HHS U54 CA209971
6 · The paper itself

Abstract

Although all-trans-retinoic acid (atRA) is a key regulator of intestinal immunity, its role in colorectal cancer (CRC) is unknown. We found that mice with colitis-associated CRC had a marked deficiency in colonic atRA due to alterations in atRA metabolism mediated by microbiota-induced intestinal inflammation. Human ulcerative colitis (UC), UC-associated CRC, and sporadic CRC specimens have similar alterations in atRA metabolic enzymes, consistent with reduced colonic atRA. Inhibition of atRA signaling promoted tumorigenesis, whereas atRA supplementation reduced tumor burden. The benefit of atRA treatment was mediated by cytotoxic CD8(+) T cells, which were activated due to MHCI upregulation on tumor cells. Consistent with these findings, increased colonic expression of the atRA-catabolizing enzyme, CYP26A1, correlated with reduced frequencies of tumoral cytotoxic CD8(+) T cells and with worse disease prognosis in human CRC. These results reveal a mechanism by which microbiota drive colon carcinogenesis and highlight atRA metabolism as a therapeutic target for CRC.

Indexed as

AnimalsCarcinogenesisCD8-Positive T-LymphocytesColonColorectal NeoplasmsFemaleHumansMiceMice, Inbred C57BLMicrobiotaRetinoic Acid 4-HydroxylaseSignal TransductionTretinoinUp-RegulationRetinoic Acid 4-HydroxylaseTretinoin

Identifiers

PMID27590114
PMCPMC5132405
OpenAlexW2513840724

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.